Calyxt, Inc. - stock earnings
Stock symbol CLXT is outdated, potentially delisted? Maybe it is available on other exchange?
CLXT Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q1 | -6.3 million USD | 42000 USD |
| 2022Q4 | -2.8 million USD | 42000 USD |
| 2022Q3 | -6.0 million USD | 42000 USD |
| 2022Q2 | -2.5 million USD | 41000 USD |
| 2022Q1 | -5.6 million USD | 32000 USD |
| 2021Q4 | -7.1 million USD | 1.9 million USD |
| 2021Q3 | -7.3 million USD | 7.8 million USD |
| 2021Q2 | -4.8 million USD | 11.9 million USD |
| 2021Q1 | -10.0 million USD | 4.4 million USD |
| 2020Q4 | -13.4 million USD | 13.9 million USD |
| 2020Q3 | -9.5 million USD | 5.2 million USD |
| 2020Q2 | -10.9 million USD | 2.3 million USD |
| 2020Q1 | -11.1 million USD | 2.4 million USD |
| 2019Q4 | -12.2 million USD | 3.8 million USD |
| 2019Q3 | -10.7 million USD | 3.0 million USD |
| 2019Q2 | -9.4 million USD | 408000 USD |
| 2019Q1 | -7.4 million USD | 157000 USD |
| 2018Q4 | -8.5 million USD | 2000 USD |
| 2018Q3 | -7.5 million USD | 27000 USD |
| 2018Q2 | -7.6 million USD | 196000 USD |
| 2018Q1 | -4.4 million USD | 11000 USD |
| 2017Q4 | -6.8 million USD | 186000 USD |
| 2017Q3 | -12.9 million USD | 44000 USD |
| 2017Q2 | -3.4 million USD | 223000 USD |
| 2017Q1 | -2.8 million USD | 55000 USD |
| 2016Q4 | -4.6 million USD | 72000 USD |
| 2016Q3 | -2.5 million USD | 105000 USD |
| 2016Q2 | -2.5 million USD | 116000 USD |
| 2016Q1 | -2.6 million USD | 106000 USD |
| 2015Q4 | -5.9 million USD | 1.3 million USD |
CLXT Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -16.9 million USD | 157000 USD |
| 2021 | -29.2 million USD | 26.0 million USD |
| 2020 | -44.8 million USD | 23.9 million USD |
| 2019 | -39.6 million USD | 7.3 million USD |
| 2018 | -27.9 million USD | 236000 USD |
| 2017 | -26.0 million USD | 508000 USD |
| 2016 | -12.1 million USD | 399000 USD |
| 2015 | -5.9 million USD | 1.3 million USD |
CLXT
Price: $6.30
52 week price:
Earnings Per Share: -2.70 USD
P/E Ratio: -3.73
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 1.8 million
Ebitda: -12.8 millionMarket Capitalization: 31.3 million